Ally Bridge Group
Status
ACTIVE
Global HQ
Gent, Belgium
Countries of investment
- USA
Investment stages
- Seed
Industries
- IT
About
Ally Bridge Group is a global healthcare investment management firm focused on high impact life science innovation. The firm was founded in 2013 by Frank Yu, who serves as Chief Executive Officer and Chief Investment Officer. It has managed over $6 billion in transactions across healthcare subsectors, with the mission to generate superior riskadjusted returns for investors while addressing unmet medical needs through the blend of scientific research and Capital markets expertise. Ally Bridge Group operates from offices in New York and Hong Kong and invests in both private and public Equity in the healthcare industry.
Ally Bridge Group is a global healthcare investment management firm focused on high impact life science innovation. The firm was founded in 2013 by Frank Yu, who serves as Chief Executive Officer and Chief Investment Officer. It has managed over $6 billion in transactions across healthcare subsectors, with the mission to generate superior riskadjusted returns for investors while addressing unmet medical needs through the blend of scientific research and Capital markets expertise. Ally Bridge Group operates from offices in New York and Hong Kong and invests in both private and public Equity in the healthcare industry.
Investment Thesis
Ally Bridge Group focuses on high impact life science innovation, investing across the global healthcare industry to address unmet medical needs while generating superior riskadjusted returns.
Portfolio
BioTherapeutics
Genetron Holdings
iTeos Therapeutics